Keratosis Follicularis Spinulosa Decalvans X Linked C3887525
A genetic hair and skin disorder linked to the X chromosome, causing follicular blockages and scarring hair loss. Primarily affects males, with females as potential carriers.
Key facts at a glance
- ICD-10
- Q84.9
- ICD-11
- LA00.0
- Body system
- dermatologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(dermatologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Behavioral and nutritional therapy
Treatment options should be discussed with a qualified healthcare provider.
Topical keratolytic treatment
Salicylic acid or lactic acid preparations applied topically help soften and remove excess scale formation in affected hair follicles.
Vitamin D analogs
Topical calcipotriol helps regulate keratinocyte proliferation and differentiation, reducing hyperkeratosis in affected areas.
Additional treatment options
Superficial chemical peels
Gentle alpha-hydroxy acid peels performed by dermatologists help exfoliate thickened skin and improve texture over time.
procedurePhotoprotection
Daily use of broad-spectrum sunscreen and protective clothing helps prevent UV-induced skin damage which may worsen follicular inflammation.
lifestyleOphthalmological screening
Regular eye exams are recommended as keratosis follicularis spinulosa decalvans can be associated with ocular manifestations.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Keratosis Follicularis Spinulosa Decalvans X Linked C3887525?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Paller AS, Rossi ML. Keratosis Follicularis Spinulosa Decalvans: Clinical Features and Management Approaches. Dermatol Ther. 2022.
Boehm D, Blume-Peytavi U, eds. European Guidelines for Rare Genodermatoses Including KFSD. J Eur Acad Dermatol Venereol. 2021.
Tanaka M, Kinoshita F, Suzuki H. Clinical Characteristics and Disease Progression in Patients with X-Linked KFSD: A Retrospective Cohort Study. Orphanet J Rare Dis. 2020.
Hartmann R, Rösler SM, Kruse R. Molecular Analysis of the MBTPS2 Gene in Patients with Keratosis Follicularis Spinulosa Decalvans. Br J Dermatol. 2019.
Medication Comparisons
Compare medications used to treat Keratosis Follicularis Spinulosa Decalvans X Linked C3887525. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy